Amyloid β-Protein (33-42)
| Name | Amyloid β-Protein (33-42) |
| Category | Beta-Amyloidand Related Peptides |
| One Letter Code | GLMVGGVVIA |
| Three Letter Code | {Gly}{Leu}{Met}{Val}{Gly}{Gly}{Val}{Val}{Ile}{Ala} |
| Molecular Weight | 915.170 |
| Application | Alzheimer's Disease |
| Pinotsi, Dorothea, et al. "Proton transfer and structure-specific fluorescence in hydrogen bond-rich protein structures." Journal of the American Chemical Society 138.9 (2016): 3046-3057. |
| Chan, Fiona TS, et al. "Protein amyloids develop an intrinsic fluorescence signature during aggregation." Analyst 138.7 (2013): 2156-2162. |
| Li, Huiyuan, et al. "Biophysical characterization of Aβ42 C-terminal fragments: inhibitors of Aβ42 neurotoxicity." Biochemistry 49.6 (2010): 1259-1267. |
| Walsh, Dominic M., et al. "Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation." Journal of Neuroscience 25.10 (2005): 2455-2462. |